本页面由Tiger Trade Technology Pte. Ltd.提供服务

Dermata Therapeutics Inc

0.8896
-0.1304-12.78%
成交量:4.49万
成交额:4.21万
市值:440.82万
市盈率:-0.20
高:1.01
开:1.00
低:0.8867
收:1.02
52周最高:4.66
52周最低:0.8867
股本:495.52万
流通股本:383.09万
量比:2.78
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-4.3864
每股收益(LYR):-8.1609
净资产收益率:-183.89%
总资产收益率:-89.88%
市净率:1.26
市盈率(LYR):-0.11

数据加载中...

2022/05/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/04

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/04/25

重要事件披露

8-K - Current report
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/03/02

重要事件披露

8-K - Current report
2022/02/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/02/04

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/02/04

重要事件披露

8-K - Current report
2022/02/04

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/01/13

重要事件披露

8-K - Current report
2021/12/10

重要事件披露

8-K - Current report
2021/12/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/26

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/01

重要事件披露

Dermata Therapeutics, Inc.
2021/09/01

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/09/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence